This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 8 from Patent US 20030077289
General Information
DRACP ID DRACP01233
Peptide Name Sequence 8 from Patent US 20030077289
Sequence GALFLGWLGAAGSTMGAWSQPKKKRKV
Sequence Length 27
UniProt ID Not available
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C131H209N37O32S
Absent amino acids CDEHINY
Common amino acids G
Mass 331034
Pl 12
Basic residues 5
Acidic residues 0
Hydrophobic residues 11
Net charge 5
Boman Index -1130
Hydrophobicity -14.07
Aliphatic Index 68.89
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: >10 hour
Extinction Coefficient cystines 11000
Absorbance 280nm 423.08
Polar residues 8
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2003/0077289 A1
Patent Title Use of cell-penetrating peptides to generate antitumor immunity.
Other Iinformation Granted Patent Family: 6s / 6ex; Family Jurisdictions: CN, WO, AU, US; Legal Status: Discontinued; Application No: 7755502; Filed:Feb 15, 2002; Published: Apr 24, 2003; Earliest Priority: Feb 15, 2001
Other Published ID CN1309417C CN1503628A WO2002064057A2 WO2002064057A3
This work is licensed under a Creative Commons Attribution 4.0 International License.